loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Amosulalol Hydrochloride, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Amosulalol Hydrochloride

    APIs // Active Pharmaceutical Ingredients

    PharmaCompass

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    One Pharma aims to be one of the leading generic companies in Europe.

    2D Structure
    1. Also known as: Amosulalol hcl, 93633-92-2, 70958-86-0, Amosulalol monohydrochloride, Ym 09538, Ym-09538
    Molecular Formula
    C18H25ClN2O5S
    Molecular Weight
    416.9  g/mol
    InChI Key
    JRVCPDVOFCWKAG-UHFFFAOYSA-N
    FDA UNII
    4O4S698PEE
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    5-[1-hydroxy-2-[2-(2-methoxyphenoxy)ethylamino]ethyl]-2-methylbenzenesulfonamide;hydrochloride
    2.1.2 InChI
    InChI=1S/C18H24N2O5S.ClH/c1-13-7-8-14(11-18(13)26(19,22)23)15(21)12-20-9-10-25-17-6-4-3-5-16(17)24-2;/h3-8,11,15,20-21H,9-10,12H2,1-2H3,(H2,19,22,23);1H
    2.1.3 InChI Key
    JRVCPDVOFCWKAG-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=C(C=C(C=C1)C(CNCCOC2=CC=CC=C2OC)O)S(=O)(=O)N.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    4O4S698PEE
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methylbenzenesulfonamide

    2. Amosulalol

    3. Ym 09538

    4. Ym-09538

    2.3.2 Depositor-Supplied Synonyms

    1. Amosulalol Hcl

    2. 93633-92-2

    3. 70958-86-0

    4. Amosulalol Monohydrochloride

    5. Ym 09538

    6. Ym-09538

    7. 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methylbenzenesulfonamide Hydrochloride

    8. Lowgan

    9. Amosulalol Hydrochloride [jan]

    10. Amosulalol (hydrochloride)

    11. 4o4s698pee

    12. 93633-92-2 ( Hcl)

    13. 5-[1-hydroxy-2-[2-(2-methoxyphenoxy)ethylamino]ethyl]-2-methylbenzenesulfonamide;hydrochloride

    14. Amosulalolhcl

    15. Unii-4o4s698pee

    16. Lowgan (tn)

    17. Schembl50631

    18. Amosulalol Hydrochloride (jp17)

    19. Chebi:31208

    20. Dtxsid00918277

    21. (+-)-5-hydroxy-2-(2-(2-methoxyphenoxy)ethylamino)ethyl)-2-methylbenzolsulfonamid Hydrochlorid

    22. Amosulalol Hydrochloride [mart.]

    23. Amosulalol Hydrochloride [who-dd]

    24. Amosulalol Monohydrochloride [mi]

    25. Benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, Hydrochloride, (+-)-

    26. Benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, Monohydrochloride

    27. D01469

    28. Q27260271

    29. 5-(1-hydroxy-2-{[2-(2-methoxyphenoxy)ethyl]amino}ethyl)-2-methylbenzene-1-sulfonamide--hydrogen Chloride (1/1)

    30. Benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, Hydrochloride (1:1)

    31. Benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, Hydrochloride, (+/-)-

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 416.9 g/mol
    Molecular Formula C18H25ClN2O5S
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count9
    Exact Mass416.1172708 g/mol
    Monoisotopic Mass416.1172708 g/mol
    Topological Polar Surface Area119 Ų
    Heavy Atom Count27
    Formal Charge0
    Complexity510
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Adrenergic beta-Antagonists

    Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    Adrenergic alpha-Antagonists

    Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)

    Post Enquiry
    POST ENQUIRY